Scarica l'app Stockscreener
0.3753
1.41%
0.0052
Pre-mercato:
.37
-0.0053
-1.41%
Precedente Chiudi:
$0.3701
Aprire:
$0.372
Volume 24 ore:
480.99K
Relative Volume:
0.83
Capitalizzazione di mercato:
$22.04M
Reddito:
-
Utile/perdita netta:
$-123.46M
Rapporto P/E:
-0.1449
EPS:
-2.59
Flusso di cassa netto:
$-104.11M
1 W Prestazione:
-4.36%
1M Prestazione:
+6.62%
6M Prestazione:
-16.34%
1 anno Prestazione:
-80.14%
Intervallo 1D:
$0.365
$0.386
Intervallo di 1 settimana:
$0.3533
$0.397
Portata 52W:
$0.2601
$2.525
Bioatla Inc Stock (BCAB) Company Profile
Nome
Bioatla Inc
Settore
Industria
Telefono
858-558-0708
Indirizzo
11085 TORREYANA ROAD, SAN DIEGO
Confronta BCAB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BCAB
Bioatla Inc
|
0.3753 | 22.82M | 0 | -123.46M | -104.11M | -2.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.36 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.01 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.31 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.97 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
309.33 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Bioatla Inc Stock (BCAB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-13 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-11-13 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-09-15 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-05-05 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-03-21 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-15 | Ripresa | BTIG Research | Buy |
| 2021-06-28 | Iniziato | ROTH Capital | Buy |
| 2021-05-05 | Ripresa | Credit Suisse | Outperform |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-01-11 | Iniziato | BTIG Research | Buy |
| 2021-01-11 | Iniziato | Credit Suisse | Outperform |
| 2021-01-11 | Iniziato | JP Morgan | Overweight |
| 2021-01-11 | Iniziato | Jefferies | Buy |
Mostra tutto
Bioatla Inc Borsa (BCAB) Ultime notizie
What analysts say about BioAtla Inc. stock outlookTrade Entry Summary & Reliable Price Breakout Alerts - beatles.ru
BioAtla Inc. Recovery Hinges on Volume Breakout2025 Fundamental Recap & High Accuracy Trade Signal Alerts - beatles.ru
Will BioAtla Inc. see short term momentumJuly 2025 WrapUp & Daily Profit Focused Stock Screening - Newser
Visualizing BioAtla Inc. stock with heatmapsInsider Buying & Reliable Breakout Forecasts - Newser
Detecting support and resistance levels for BioAtla Inc.July 2025 Setups & High Yield Equity Trading Tips - Newser
Has BioAtla Inc. formed a bullish divergenceJuly 2025 Levels & Technical Buy Zone Confirmations - Newser
BioAtla Inc. stock momentum explained2025 Key Lessons & Weekly Top Gainers Alerts - Newser
Is BioAtla Inc. stock bottoming outPortfolio Performance Summary & Risk Controlled Swing Alerts - Newser
Is it time to cut losses on BioAtla Inc.Profit Target & Low Risk Entry Point Guides - Newser
BioAtla Inc. Tests 50 Day MA After Sharp DeclineWeekly Investment Report & Weekly Watchlist for Hot Stocks - Newser
Technical Models Suggest BioAtla Inc. May Rebound SoonDay Trade & AI Enhanced Trading Alerts - beatles.ru
How to forecast BioAtla Inc. trends using time seriesRate Hike & Free Community Supported Trade Ideas - Newser
How sentiment analysis helps forecast BioAtla Inc.Market Trend Review & Smart Investment Allocation Insights - Newser
Using data filters to optimize entry into BioAtla Inc.2025 Retail Activity & Risk Managed Investment Signals - Newser
Sector ETF performance correlation with BioAtla Inc.Gap Up & Community Consensus Trade Alerts - Newser
Can BioAtla Inc. rally from current levelsEarnings Summary Report & Accurate Entry/Exit Alerts - Newser
BioAtla Inc. Stock Performance After Earnings: Historical InsightsTrade Volume Report & Risk Controlled Daily Plans - Newser
BioAtla’s Earnings Call: Positive Clinical Progress Amid Financial Challenges - MSN
BioAtla Inc. Testing Reversal Zone on Weekly Chart2025 Top Decliners & Free Long-Term Investment Growth Plans - classian.co.kr
Combining price and volume data for BioAtla Inc.Stop Loss & High Accuracy Swing Entry Alerts - Newser
What technical models suggest about BioAtla Inc.’s comebackJuly 2025 Rallies & Verified Entry Point Detection - Newser
Exit strategy if you’re trapped in BioAtla Inc.Quarterly Trade Summary & Risk Managed Investment Signals - Newser
BioAtla downgraded to Market Perform from Outperform at Citizens JMP - MSN
JMP Securities Reiterates “Market Perform” Rating for BioAtla (NASDAQ:BCAB) - Defense World
BioAtla (NASDAQ:BCAB) Rating Lowered to Market Perform at Citizens Jmp - Defense World
BioAtla's BCAB Downgraded to Market Perform by JMP Securities - AInvest
HC Wainwright Predicts BioAtla’s Q3 Earnings (NASDAQ:BCAB) - Defense World
BioAtla’s SWOT analysis: oncology biotech’s stock faces cash crunch By Investing.com - Investing.com South Africa
BioAtla’s SWOT analysis: oncology biotech’s stock faces cash crunch - Investing.com
Citizens JMP Downgrades BioAtla(BCAB.US) to Hold Rating - 富途牛牛
BioAtla stock downgraded by Citizens JMP on cash concerns - Investing.com Canada
Will BioAtla Inc. see short term momentum [2025 Market Trends]Accurate Intraday Trading Signals - Newser
Why BioAtla Inc. stock attracts strong analyst attentionDay Trading Plan with Entry Risk Management - Newser
Analysts Apply Wyckoff Model to BioAtla Inc. StockBuy Low Sell High Stock Watch Strategy in Focus - 선데이타임즈
BioAtla, Inc. (NASDAQ:BCAB) Q2 2025 Earnings Call Transcript - Insider Monkey
Bioatla Inc Azioni (BCAB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.44%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):